Longeveron Co-Authors Important ICSFR Task Force Paper On Aging Frailty

MIAMI, Aug. 20, 2018 /PRNewswire/ -- Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the International Conference on Frailty & Sarcopenia Research (ICSFR) Task Force has published a key paper on Aging Frailty, a...